1201 Hanley Road
Hudson, WI 54016
Year Founded: 1964
Number of Employees: 3400
Number of Facilities: 19 facilities throughout the United States,
Europe, Mexico and China
WHO WE ARE
Phillips-Medisize, a Molex company, is a leading global
outsource provider of design and manufacturing services to
the medical (medical device, diagnostics, and drug delivery
products) and commercial (automotive, consumer, and defense)
markets. The company has 85% of its total revenue coming
from drug delivery, medical devices, diagnostic products, and
primary pharmaceutical packaging.
Drug delivery, medical device, diagnostic products such as disposable
insulin pens, glucose meters, specialty inhalation drug delivery
devices, single use surgical devices and consumable diagnostic
components, along with primary pharmaceutical packaging.
Phillips-Medisize partners globally with its customers to provide
design and development services with hubs in Hudson,
Wisconsin and Struer, Denmark, which are supported by
facilities in North America, Europe, and China. This global
network accelerates speed to market of innovative products
and works with customers to deploy advanced quality control
technologies, which reduce manufacturing cost while improving
quality. The company’s core advantage is the knowledge of its
people to integrate design, molding, and automation to drive
low cost and high quality manufacturing solutions.
Medical OEMs rely on Phillips-Medisize for guaranteed
confidentiality, secure facilities, and superior solutions in a full
range of technologies:
Design and Development
Phillips-Medisize offers full turnkey development, from strategy
to a unique 5-phased design and development process, which
leading medical OEMs rely on. This process also enhances
speed to market.
Phillips-Medisize offers superior solutions in a full range of
technologies, such as plastic injection molding, metal injection
molding, magnesium injection molding, multi-shot liquid silicone
rubber molding, and micro molding.
Phillips-Medisize has world-class expertise and decades of
assembly experience. Our fully equipped clean rooms feature
manual, semi-automated, and fully automated production lines
capable of handling millions of components or finished devices.
Phillips-Medisize is FDA-registered and compliant 21 CFR
820 and 210/211 for drug packaging and drug handling
for drug coating applications. Manual, semi-automated, and
fully automated capabilities include design and manufacture of
products ranging from dropper systems and bottles to single-and multi-chamber bags and bottle closures.
Supply Chain Management
Phillips-Medisize assumes responsibility for the supply of all raw
materials and custom critical components required to support
the complete finished product, such as drug handling with cold
chain. Phillips-Medisize believes supply chain management is
the cumulative effort of all the company’s disciplines involved in
taking an order, producing the order and delivering the order.
Supply chain management requires trust between all parties:
suppliers, the outsourcer, and the customer.
Quality is top priority at Phillips-Medisize. The Company’s QMS
process is adaptable to global requirements, integrated for drug
handling with cold chain storage and supports class I, II, and III
devices. Phillips-Medisize is:
• FDA registered and compliant to the cGMPs
• Compliant to 21 CFR 820 and 210/211
• Certified to ISO 13485, 14001, and 9001
• MHRA EU GMP certification
• MHLW certification